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ABSTRACT
Filamentous phage display has been extensively
used to select proteins with binding properties of
specific interest. Although many different display
platforms using filamentous phage have been
described, no comprehensive comparison of their
abilities to display similar proteins has been con-
ducted. This is particularly important for the
display of cytoplasmic proteins, which are often
poorly displayed with standard filamentous phage
vectors. In this article, we have analyzed the ability
of filamentous phage to display a stable form of
green fluorescent protein and modified variants in
nine different display vectors, a number of which
have been previously proposed as being suitable
for cytoplasmic protein display. Correct folding
and display were assessed by phagemid particle
fluorescence, and with anti-GFP antibodies. The
poor correlation between phagemid particle fluores-
cence and recognition of GFP by antibodies,
indicates that proteins may fold correctly without
being accessible for display. The best vector used
a twin arginine transporter leader to transport the
displayed protein to the periplasm, and a coil-coil
arrangement to link the displayed protein to g3p.
This vector was able to display less robust forms
of GFP, including ones with inserted epitopes, as
well as fluorescent proteins of the Azami green
series. It was also functional in mock selection
experiments.
INTRODUCTION
Phage display using ﬁlamentous phage vectors is a widely
used method for the selection of speciﬁc proteins and
peptides from large libraries (1–4). Unlike lytic phage,
ﬁlamentous phage is released by secretion. This imposes
a constraint on displayed proteins, since they have to cross
the inner membrane as part of phage assembly. While this
does not appear to cause problems for antibody fragments
[e.g. scFvs (5–7) or Fabs (8–11)] or other usually secreted
proteins, such as the ﬁbronectin domain (12), proteins
which are normally expressed and fold within the cyto-
plasm can have more diﬃculty.
Filamentous phage have ﬁve coat proteins (p3, p6, p7,
p8 and p9), each of which has been used for display in one
form or another (Table 1), with display at the N terminus
of p3 (13,14) being most commonly used. In most N
terminal display systems [p8 (15), p7 (16), p9 (17) and
p7+ p9 together (18)], the displayed protein is trans-
ported across the inner membrane to the periplasmic
space using a Sec based leader, such as PelB. This also
includes display with p7 and p9 (16–18), in which a Sec
based leader is appended to the N terminus, even though
the wild-type proteins lack such leaders. As a result, each
of these display vectors is likely to suﬀer from the same
constraints as the standard p3 display vectors. Display
vectors relying on the C terminal end of p3 (19) or p6
(20–22) have been proposed as being more suitable for
the display of cytoplasmic proteins, since the C terminus
of these proteins is found in the bacterial cytoplasm prior
to phage assembly (23), and folding of the displayed
protein is therefore thought to occur within the cytoplasm.
The C terminus of p8 also resides in the cytoplasm
and has been used for display of both proteins and
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appears to require tailored optimization for the speciﬁc
protein being displayed. Of the remaining two minor
coat proteins, for which C terminal display has not been
attempted, the C terminus of p7 is extremely hydrophobic
and thought to be buried within the membrane (26), while
that of p9 is relatively hydrophilic, and may be found
partly within the cytoplasm (26), suggesting that it too
may be eﬀective as a C terminal display protein.
An alternative strategy to the use of diﬀerent display
proteins, is the use of diﬀerent translocation systems to
target the displayed protein to the periplasmic space.
Most proteins that cross the inner bacterial membrane
do so using the type II secretory system. This comprises
three diﬀerent pathways: Sec, SRP (Signal Recognition
Particle) and TAT (Twin Arginine Transport). The Sec
pathway translocates proteins post-translationally (27–
29), the SRP pathway translocates co-translationally
(30,31), and both pathways converge at the Sec
translocon, which transports proteins in an unfolded
state across the inner membrane. This is in contrast to
the TAT pathway which only translocates proteins that
have already folded in the cytoplasm across the inner
membrane (32–35). This has been widely used to transport
folded and ﬂuorescent GFP from the cytoplasm to the
periplasm (36–40), as well as in a genetic selection
system for correctly folded proteins (41). Recently, in an
attempt to display otherwise undisplayable proteins, SRP
(42) and TAT (43) leaders were used in phage display
constructs. The SRP leader was used to display ankyrin
based binding proteins, while the TAT leader was used to
display a circular GFP permutant. In both cases, the
previous use of standard phage display vectors with the
Sec leader was unsuccessful. Speciﬁc ankyrin based
binders could be selected from phage libraries using SRP,
but not from similar Sec based libraries, while in the case of
the TAT based display vector, a peptide linker fused to a
circular permutant of GFP could be speciﬁcally recognized
on phage. However, the display of ﬂuorescent GFP was not
demonstrated, suggesting that correctly folded and func-
tional GFP may not have been displayed in this latter
study.
Although this represents an apparently wide choice of
potential display systems, no systematic comparison
has ever been made between them, and it is not at all
clear which system, if any, is generally most appropriate
for the display of proteins, which normally fold in the
cytoplasm.
In addition to the ﬁlamentous phage platform, a
number of lytic cytoplasmic phages have also been used
for display purposes. T7, an extensively studied double-
stranded DNA phage assembled in the cytoplasm and
released by cell lysis (44), is the cytoplasmic phage most
widely used for display purposes (45–53), in large part
because it is available commercially. A comparison
between T7 and ﬁlamentous phage g3p (with a Sec
leader) for peptide display, showed signiﬁcantly less bias
with T7 (54). A similar comparison between the D protein
of lambda and g3p or g8p of ﬁlamentous phage (using Sec
leaders) for the display of a hepatitis C cDNA library (55),
also showed the superiority of the lytic phage for display
of the predominantly cytoplasmic proteins, and we have
recently shown display of GFP libraries in T7 (56). The
problem with lytic phage is the large size of their genomes,
and the relative diﬃculty of preparing eﬀective in vitro
packaging mixtures (especially T7). Although this has
been overcome by the availability of commercial kits,
they tend to be expensive, and the use of this phage is to
be contrasted with the relative ease, with which ﬁlamen-
tous phage libraries can be prepared, propagated, selected
and analyzed using phagemid vectors. Consequently, a
ﬁlamentous phage system eﬀective for cytoplasmic
proteins would be extremely useful.
GFP is a widely used ﬂuorescent protein marker, natu-
rally expressed and folded in the cytoplasm, that has been
used to track the distribution of many diﬀerent
predominantly cytoplasmic fusion partners, in many diﬀer-
ent organisms (57–60). In bacteria, functional ﬂuorescent
GFP can be easily expressed in the cytoplasm, but not the
periplasm (61). As GFP only becomes ﬂuorescent when
correctly folded (62), it should be usable as a general sur-
rogate to assess the eﬀectiveness of diﬀerent display
systems to display cytoplasmic proteins. Although GFP,
or variants of it, have been displayed on the surface of a
number of organisms, including Escherichia coli (63,64),
yeast (65,66), hepatitis B (67), baculovirus (68–70), T7
(56) and adenovirus (71) it is striking that no publication
has described and analyzed the display of GFP on ﬁlamen-
tous phage, suggesting that in its present formats, it is
poorly suited for cytoplasmic protein display.
In order to determine whether it is possible to display
cytoplasmic proteins using ﬁlamentous phage, we have
Table 1. Display proteins used in ﬁlamentous phage display
Display
protein
Natural
leader
Leader used Display format Proteins displayed References
g3p Sec Sec N terminus Widely used: antibody fragments,
peptides, other proteins
(6,13,102,103)
Sec/Sec N terminus, jun-fos linkage
between displayed protein and g3p
cDNA libraries (80,81)
TAT/Sec cpGFP (but not ﬂuorescent) (43)
Sec C terminus Tyrosine kinase (19)
g6p None None C terminus cDNA libraries (20,21)
g8p Sec Sec N terminus Peptides, Antibody fragments (15, 104–106)
Sec C terminus Peptides (24)
g7p None Sec N terminus VH (18)
g9p None Sec N terminus VL, scFv (17,18)
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display system (5). These nine vectors exploit diﬀerent
display proteins and diﬀerent leaders, and in a ﬁrst set
of experiments were used to display superfolder GFP
(sfGFP) (72), a particularly stable form of GFP, and
derivatives of it. The best vectors were then also tested
on other ﬂuorescent proteins.
MATERIALS AND METHODS
Bacterial strains
DH5aF0:F 0/endA1 hsdR17(rK mK+) supE44
thi-1 recA1 gyrA (Na1r) relA1 D(lacZYAargF) U169
(m80lacZDM15)
Omnimax: F0 {proAB lacIq lacZM15 Tn10(TetR)
(ccdAB)} mcrA (mrr hsdRMS-mcrBC) 80(lacZ)M15
(lacZYA-argF)U169 endA1 recA1 supE44 thi-1 gyrA96
relA1 tonA panD
Construction of vectors and ﬂuorescent protein
based inserts
The sequences of all named oligos are provided in Table 2.
The Np3-Sec vector used is pDAN5, our standard phage
display vector for scFv antibody display. Np3-SRP was
created by assembling the SRP leader from the DsbAss
gene with two phosphorylated oligonucleotides, DsbAss S
and DsbAss AS. When annealed these oligos create
overhanging ends which can be ligated directly into
pDAN5-D1.3 cut with HindIII and NheI, replacing the
pelB leader with the DsbAss SRP leader. Np3-TAT
was created by assembling three oligonucleotides
(TorA1HindIII, TorA2BssHII and TorA3) that together
encoded the TorA leader. This contained HindIII, 26bp of
the TorA 50 untranslated region, including the Shine-
Dalgarno sequence, the full TorA leader, the ﬁrst four
codons of the mature TorA protein and an in frame
BssHII site. The ﬁrst four codons of the mature TorA
protein were included to facilitate translocation, as a
result of which, the gly-ala-his-ala extension described
above is expected to be retained, rather than removed,
during translacation. The gene was cloned into pDAN5
using HindIII and BssHII. Np9-TAT-GFP was created
from Np3-TAT by amplifying Np3-TAT-GFP with
Np3TATNotI50 and Np3TATBamHI30, and amplifying
M13mp19 with gene9 50 and gene9 30. The ampliﬁed g9
was cloned into the ampliﬁed plasmid using NotI and
BamHI. This replaced the g3 with g9, and added a
glycine/serine linker to the 50-end of g9. It also eliminated
the His6 tag in Np3-TAT. To create Cp3, gene 3 was
Table 2. Oligonucleotides used
Oligo name Oligo sequence
DsbAss S P-AGC TTG CCA AAT TCT ATT TCA AGG AGA CAG TCA TAA TGA AAA AAA TCT GGC TGG CGC TGG
CAG GCC TGG TGC TGG CGT TTA G
DsbAss AS P-CGC GCA AAC GCC AGC ACC AGG CCT GCC AGC GCC AGC CAG ATT TTT TTC ATT ATG ACT GTC
TCC TTG AAA TAG AAT TTG GCA
TorA1HindIII GAC GTA AAG CTT CAC GGC GAT AAG AAG GAA GAA AAA TAA TGA ACA ATA ACG ATC TCT TTC
AGG CAT CAC GTC GG
TorA2BssHII TTT CAG GCA TCA CGT CGG CGT TTT CTG GCA CAA CTC GGC GGC TTA ACC GTC GCC GGG ATG
CTG GGG CCC TCA
TorA3 TCC GGC ATG CGC GCC CGC CGC TTG CGC CGC AGT CGC ACG TCG CGG CGT TAA CAA TGA GGG
CCC CAG CAT CCC
gene3Mlu1-50 CAT CAC CAC GCG TTG GCC GCC ACT GTT GAA AGT TGT TTA
gene3EcoRI-30 GAG AGA GAA TTC GGC ATG CGC GCC ACG ATC GGT TTC CGC GCT AGA ATA AGA CTC CTT ATT
ACG CAG TAT G
pDpH 50 GCA GCC GCT GGA TTG TTA TTA
pDpH 30 TTG TCG TCT TTC CAG ACG TTA
His6-EcoRI-30 AGT AGC GAA TTC TTA ATG GTG ATG GTG ATG GTG AGT
gene 6 50 TTC TTA AGC TTG CCA AAT TCT ATT TCA AGG AGA CAG TAC ATA TGC CAG TTC TTT TGG GTA
gene 6 30 GGC ATG CGC GCC GCT ACC ACC ACC GCT ACC ACC ACC GGA TCC TTT ATC CCA ATC CAA ATA AGA
gene 9 Hind3 50 TTC TTA AGC TTG CCA AAT TCT ATT TCA AGG AGA CAG TAC ATA TGA GTG TTT TAG TGT ATT
gene 9 BssH2 30 GGC ATG CGC GCC GCT ACC ACC ACC GCT ACC ACC ACC GGA TCC TGA GGA AGT TTC CAT TA
gene 9 50 GGC GGT GGA TCC ATG AGT GTT TTA GTG TAT T
gene 9 30 CTC CAA GCG GCC GCA TAT GAC CGG TTT ATG AGG AAG TTT CCA TTA
Np3TATNotI50 TAA ACC GGT CAT ATG CGG CCG CTT GGA GAA TTC ACT GGC CGT CGT TTT AC
Np3TATBamH130 CTC ATG GAT CCA CCG CCA CCG CTA CCG CCA CCA CCA GTA CTA TCC AGG CCC AGC AGT G
PelB 50 TTC TTC TCG CGG CCG GGT GAT GCC AAA TTC TAT TTC AAG G
PelB 30 GGC GTG CGC ACC GCT TGC TGC
Kcoil 50 GCA GCA AGC GGT GCG CAC GCC AAA GTA AGC GCT CTC AAG GAA
Kcoil 30 AGA GAT CGG TAA GAA AAG CGG CCG CAG AAC CGC CAG AGC CAC CAC CCT CTT TCA GGG
CGC TCA CAA A
PelBcys 50 TAC AAA GCT AGC AGC GGC AAA CCA ATC CCA AAC CCA CTG CTG GGC CTG GAT AGT ACT CAC
CAT CAC CAT CAC CAT TGC TGA GCC AAA TTC TAT TTC AAG G
PelBcys 30 TTC AAC AGT AGC GGC CGC GCA GTA GTC GGC GTG CGC ACC GCT TGC TGC GAG TAA TA
Bad-Hugh3 50 GCA AGC GGC GCG CAT GCC GCA CTC GAG GGA GAA GAA CTT TTC ACT GGA GTT G
Bad-Hugh3 30 GCC GCT AGC TTT GTA GAG CTC ATC CAT GCC ATG TGT AAT CCC AGC AGC AGT TAC
50 DSRedDanII GGT TAG CGC GCA AGC CTC CTC CGA GGA CGT CAT CAA GGA G
30 DSRedDanII CGT AAG CTA GCC AGG AAC AGG TGG TGG C
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gene3EcoRI-30. The PCR product was cut with MluI
and EcoRI and cloned into pDAN5 D1.3 cut with
BssHII and EcoRI (MluI and BssHII are compatible) to
create pMich1. This replaced scFv-gene 3 with gene 3
alone. sfGFP (obtained from Geoﬀ Waldo) was ampliﬁed
from pDAN5-GFP using pDPH50 and His6-EcoRI-30, cut
with BssHII and EcoRI and cloned into pMich1 cut with
the same enzymes. This placed sfGFP downstream of gene
3, ﬂanked by our standard cloning sites BssHII and NheI.
Cp6 was created by amplifying gene 6 from M13mp19
with gene 6 50 and gene 6 30, cut with HindIII and
BssHII and cloned into pCp3 cut with the same
enzymes. This resulted in the replacement of p3 with p6.
In addition, an NdeI is put at the 50 and a BamHI is put at
the 30 of p6, allowing subsequent cloning of other poten-
tial display proteins if required. Cp9 was created by
amplifying gene 9 from M13mp19 with gene 9 50 and
gene 9 30, cut with HindIII and BssHII and cloned into
pCp3 cut with the same enzymes. Np3-TATcoil was
created in a two step procedure by cleaving Np3-TAT
with HindIII and NheI and cloning the insert into
pDAN5 D1.3 E coil (73) cut with the same enzymes.
This appended an E coil to the C terminus of sfGFP
upstream of the SV5 tag. Np3-TATcoil was created by
combining the PelB leader with the K coil by PCR
assembly. The PelB leader was ampliﬁed from pDAN5
using PelB 50 and PelB 30, the K coil was ampliﬁed from
pDAN5 D1.3 K coil (73) using Kcoil 50 and Kcoil 30, and
the two were combined by PCR assembly using PelB 50
and Kcoil 30. The assembled fragment was cleaved with
EagI, and cloned into Np3-TAT cleaved with NotI and
dephosphorylated. Np3-TATcys was created by
amplifying the PelB leader from pDAN5 D1.3 with
PelBcys 50 and PelBcys 30, and cloning into Np3-TAT
using NheI and NotI. The Azami Green series (74),
superfolder GFP (72), and the sfGFP derivatives clys-
GFP and myc-GFP (56) were cloned into the various
display vectors using BssHII and NheI, from our pre-
existing pET vectors (75). To clone wild type GFP and
cycle 3 GFP into pDan5 and pHugh3, the GFP coding
regions were ampliﬁed from the vector series pHisﬂexGFP
with the primers Bad-Hugh3 50 and Bad-Hugh3 30. The
amplicons were digested with BssHII and NheI, gel
puriﬁed and cloned into the appropriately digested
plasmids. DsRed T1 (76) was cloned similarly after ampli-
ﬁcation from DsRed Express (Clontech) using 50
DsRedDanII and 30 DsRedDanI, and cleavage with
BssHII and NheI.
All constructs were transformed into DH5a F0 and
sequenced prior to use.
ELISA with folded and denatured GFP
Non-denatured GFP contained 1mg of puriﬁed sfGFP in
80ml PBS. The SDS treated samples additionally
contained 2% SDS. The heat-treated sample was heated
to 100 C for 10min. After these treatments, samples were
added to Nunc Maxisorp plates and incubated for 1h at
37 C for protein adsorption. Antigen bound plate was
washed with PBS and blocked with 200ml of wonder
block (WB - 0.3% BSA, 0.3% milk, 0.3% ﬁsh gelatin)
for 1h at room temperature. The blocked plate was
washed and incubated with primary antibodies, anti
GFP 3E6 (0.5mg/ml, Q-biogene Inc.) or anti GFP
polyclonal (1mg/ml, Rockland Inc.). The secondary
antibody for 3E6 was horseradish peroxidase (HRP)
labeled anti-mouse (0.5mg/ml, Dako Inc.) and the second-
ary antibody for the anti-GFP polyclonal was HRP
labeled anti-goat (0.5mg/ml, Abcam Inc.). The plates
were washed four times with PBST (Phosphate buﬀered
saline containing 0.1% tween 20) and four times with PBS.
100ml TMB (Sigma Inc.) was used as the HRP substrate.
The reaction was quenched using 50ml 1M sulfuric acid
and absorbance read at 450nm.
Bacterial growth, phage production, phage precipitation
and quantiﬁcation
Bacteria containing the diﬀerent constructs were grown
overnight on amp/glu (50mg/ml carbenicillin, 3%
glucose) plates at 30 C. A small streak of bacteria was
added to 10ml amp/glu (50mg/ml carbenicillin, 3%
glucose) 2 TY and grown for 2h at 37 C before infection
with M13K07 helper phage at a multiplicity of infection of
10:1. After 30min at 37 C, the bacteria were pelleted by
centrifugation and re-suspended in 50ml of amp/kan
(50mg/ml carbenecillin, 25mg/ml kanamycin) 2 TY
prior to overnight growth at 30 C for phage production.
The overnight bacterial culture was centrifuged at 2500 rcf
and the supernatant PEG precipitated twice by adding
20% volume of 20% PEG 8000, 2.5M NaCl. Phage
were resuspended in a ﬁnal volume of 1ml PBS. In
order to calculate the number of phage particles in each
solution, absorbance readings at 269nm and 320nm were
taken. The titre was calculated using the following
formula (Abs. 269 Abs. 320) 6 10
16/plasmid size
(77). We had independently veriﬁed that the number of
phages calculated using this formula matched the
number of phages on a titration plates (amp phage+kan
phage) (data not shown).
Phage ELISA
MaxiSorp plates (Nunc Inc.) were used for all ELISAs.
In the antibody ELISA experiments biotinylated
antibodies (100mlo f1 0 mg/ml) were ﬁrst bound to
neutravidin adsorbed on Nunc. Maxisorp plates. 70mlo f
phage (at a concentration of 10
12/ml) and 25ml of wonder
block were added and incubated for 1h at room temper-
ature. Plates were washed with PBST (three times) and
PBS (three times). Bound phage was revealed using an
anti-M13 HRP (0.2mg/ml Amersham Pharmacia Inc.).
HRP activity was quenched using 1M sulfuric acid.
ELISA values are given as absorbance at 450nm.
Measuring phage ﬂuorescence
To measure phage ﬂuorescence, bacterial growth, and
phage quantiﬁcation were carried out as described
above. 10
12 phage were used to measure phage ﬂuores-
cence, at a gain of 98 for all measurements. For the
mAG series and sfGFP and its variants, excitation was
carried out at 488nm, and emission was measured at
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the emission value at 509nm calculated from a 500–
530nm emission scan. The ﬂuorescence of wild-type
GFP was too low to measure. For DsRed phage, excita-
tion was at 540nm and emission was measured at 595nm.
Phage titration
Ten microliter of phage solution was added to 90mlo f
2 TY media in a microtite well. A 10-fold dilution series
was carried out in the microtitre plate. 100ml of DH5a
grown to 0.5 OD600 at 37 C was added to each well and
phage infection was allowed to occur for 30min at 37 C.
5ml of the infected cells from each well were spotted on
amp/glu plates and incubated at 30 C overnight. The total
amount of phage was calculated from the dilution with the
highest number of countable colonies.
Competitive selection
Phage were prepared in 10ml volumes as described
previously. After centrifugation, the culture supernatant
was ﬁltered using a 0.22mM syringe ﬁlter. 100ml of each
of the phage were diluted into 700ml of media and 0.1%
BSA for 30min. 200ml of blocked phage were used as the
input for each selection. 1mg of biotinylated antigen was
added to the phage mix and incubated for 1h. The binding
to streptavidin magnetic beads and subsequent washes
(3  PBST, 3  PBS) were carried out using the
KingFisher automated magnetic bead handler
(ThermoFisher Inc.). Phage elution was carried out in
150ml 0.1N HCl and neutralized with 50ml 1.5M Tris
pH8.8. 50ml of eluted phage were infected into 1ml
DH5a at 0.5 OD600 at 37 C for 30min. 100mlo f
infected cells were plated on amp/glu plates in order to
pick single colonies for PCR based vector identiﬁcation.
The Np3-pelB and Np3-TATcoil vectors were recognized
using pDpH 50 and pDpH 30 primers, while the Np3-SRP
vector was identiﬁed using the DsbAss S primer as
forward and pDpH 30 as reverse primer.
Mock selection
Fifty milliliters of overnight phage cultures were prepared
and puriﬁed as described above. 10
13/ml phage solutions
for GFP and mAG displaying phages were prepared and
blocked with wonder block. sfGFP and mAG phage were
mixed in the ratios indicated in Table 3. One hundred
microliters of each phage mix was added to well A of
the KingFisher instrument (ThermoFisher) microtiter
plate. 1mg of biotinylated mAb 3E6 was also added to
the well as antigen and incubated for 1h. Binding to
streptavidin beads and selection were carried out as
detailed in the previous section. Ten microliters of eluted
phage were infected into 1ml DH5a at 0.5 OD600 at 37 C
for 30min. About 1000 infected cells were plated on amp/
glu plates on a ﬁlter and the ﬁlter was induced by transfer
to amp/IPTG plates and incubated at 30 C for 1h for
protein induction. The GFP folds and ﬂuoresces in 1h
while mAG takes about 4–5h to ﬂuoresce, allowing
straightforward identiﬁcation and counting of selected
phage. The numbers were further conﬁrmed by PCR
using GFP speciﬁc primers. The total number of
colonies was used to calculate eluted phage titers, and
numbers from 1h protein induction and PCR were used
to calculate the ratios. Input and eluted phage titers were
determined to calculate the sfGFP/mAG phage ratio
(Table 3).
Western blot analysis of phage display
Bacterial growth and phage production was carried out as
described above. Thirty microliters of PEG precipitated
phage were electrophoresed using the Novex bis-tris gel
system (Invitrogen Inc.). After electrophoresis, the
proteins were transferred to nitrocellulose membrane
using a semidry blot apparatus. The membrane was
blocked with 3% milk PBST for 1h at RT. This was
then incubated in 1mg/ml of anti-SV5 antibody in 2%
milk PBST overnight at 4 C. The blot was washed 2 
PBST and 1  PBS, 5min each. Anti-mouse HRP (Santa
Cruz biotech) at 1:2000 dilution was used as the secondary
antibody, 1h RT. After washing, the HRP activity was
detected using SuperSignal West Dura (Pierce Inc.) and
the Versa doc imager (Biorad Inc.).
RESULTS
Plasmid constructs
The constructs shown in Figure 1, each cloned between the
HindIII/EcoRI sites of pUC119, were created by PCR of
appropriate gene fragments from M13mp19 (78). In each
case, the cloning sites used for the ﬂuorescent protein were
BssHII and NheI, the same as those used in pDAN5 (5).
The BssHII site in pDAN5 is found within the 30-end of
the sequence encoding the leader, with additional
nucleotides encoding gly-ala-his-ala found downstream.
The whole of this sequence was used for all constructs.
Table 3. Mock selection
Antigen Input GFP
phage
Input mAG
phage
Ratio phage
GFP:mAG
Output GFP
phage
Output
mAG phage
Ratio phage
GFP:mAG
Bio-3E6+strep beads 1.8 10
9 0.6 10
9 3:1 1.8 10
4 0 1:0
Bio-3E6+strep beads 1.8 10
8 1.2 10
10 1:67 6 10
4 3 10
4 2:1
Bio-3E6+strep beads 0.6 10
7 3 10
10 1:5000 1.8 10
4 3.2 10
4 1:1.8
Strep beads only 1.8 10
9 0.6 10
9 3:1 0 450 0:1
Strep beads only 1.8 10
8 1.2 10
10 1:67 4.5 10
3 9 10
4 1:20
Strep beads only 0.6 10
7 3 10
10 1:5000 0 9 10
4 0:1
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GFP molecules. We would expect this to be removed in
the case of the SRP and Sec leaders, during translocation
to the periplasm, and retained in the case of the TAT
leader (see materials and methods). In addition, all
constructs contained the easily used SV5 peptide tag (79)
at the C terminus of the displayed GFP. In the case of the
p3C vector, the linker between p3 and the displayed
protein was the same as that used by Fuh et al.
(YSSAETDR) (19). For the p6C and p9C vectors, an
identical linker (GSGGGSGGGS) was used between the
C terminus and the GAHA sequence containing the
BssHII site. For the p3 TAT based display vectors, an
arrangement similar to that described by Paschke and
Hohne (43) was used, with the torA leader driving the
export of the ﬂuorescent protein, and a Sec leader (that
used in pDAN5), for translocation of p3. However, unlike
Paschke and Hohne, who used a cys-coil-cys arrangement,
based on jun/fos, we used two alternative coupling
methods to link the exported GFP to p3. This is based
on experiments (data not shown) indicating that the cys-
coil-cys arrangement, also used in the pJUFO series of
vectors (80–82), can lead to the formation of long
cysteine bonded concatamers. In the ﬁrst method (Np3-
TATcys), a cysteine was placed at the C terminus of the
ﬂuorescent protein and at the N terminus of the mature p3
(i.e. after cleavage of the pelB leader). This is based on a
successful p3 based disulﬁde bonded display system, and
the sequence around the p3 cysteine was identical to that
previously described (83). In the second method, E and K
coiled coils [that have an aﬃnity of 60pM for one another
(84)] were used, with the E coil fused to displayed protein
and the K coil to the N terminus of p3. Although previous
work (85) has shown that direct TAT-p3 fusions are
unable to display, we also created a construct of this
type, as well as a TAT-p9 fusion. All constructs were
sequenced for veriﬁcation.
Display of sfGFP
In the ﬁrst experiments described here, we used an
extremely stable form of GFP (86) (superfolder GFP –
sfGFP), as well as two previously described derivatives,
myc-GFP and clys-GFP (56,75). These are able to recog-
nize the monoclonal antibody 9E10 and the antigen
lysozyme, respectively. We adopted two criteria to deter-
mine whether sfGFP and the derivatives were correctly
folded and displayed on phage. The ﬁrst, based on the
ﬁnding that GFP is not ﬂuorescent unless it is correctly
folded (62), was the observation of ﬂuorescence in phage.
Although this shows that correctly folded sfGFP is
associated with phage, it does not show that it is in an
accessible ‘displayed’ format, i.e. recognizable by
antibodies or other targets. This was the basis for the
second criterion, carried out with an anti-GFP
monoclonal antibody that recognized a conformational
epitope exquisitely sensitive to the presence of SDS and
heat denaturation. As shown in Figure 2, 3E6 (Q-biogene)
shows strong binding to GFP, which can be signiﬁcantly
reduced if the GFP is treated with 2% SDS, and abolished
if heat treatment (10min at 100 C) is additionally applied,
a condition under which ﬂuorescence is also lost. Since
there is no loss of ﬂuorescence, the reduction of 3E6 reac-
tivity with SDS treatment may be associated with masking
of the epitope by the binding of SDS rather than protein
denaturation. It is important to note, that as the GFP
ﬂuorophore is formed after folding (62), it is possible
that a non-ﬂuorescent correctly folded GFP molecule is
able to bind this antibody. The polyclonal antibody
(Rockland Immunochemicals) binds GFP under all three
conditions.
Bacteria containing the diﬀerent constructs displaying
sfGFP were infected with helper phage and assessed for
phage production. Each of the constructs was able to
make phage at similar titers (10
12–13/ml) to those we
have routinely observed with antibody phage display
using pDAN5. The ﬂuorescence of 10
12 phagemid
particles produced by these diﬀerent vectors is shown in
Figure 3A. The ﬂuorescence of a standard p3 phage
display vector displaying a scFv is shown for comparison.
The least ﬂuorescent phage were from the Cp6 and Cp3
constructs, while the remaining phage had ﬂuorescent
levels that were similar. The presence of ﬂuorescence in
a phage preparation gives no indication as to whether
the GFP is accessible in a form suitable for display. This
was studied by phage ELISA (7 10
10 phage) using three
diﬀerent antibodies (Figure 3B): (i) anti-SV5 (79), a
monoclonal antibody recognizing the SV5 peptide tag
found at the C terminus of sfGFP; (ii) a polyclonal anti-
GFP antibody able to recognize folded and unfolded GFP
(Figure 2) and (iii) 3E6, the mAb that recognizes a GFP
conformational epitope (Figure 2). Of these, only 3E6 will
exclusively recognize GFP that is correctly folded, while
the ﬁrst two antibodies will recognize GFP or the attached
peptide whether GFP is correctly folded or not (Figure 2).
Surprisingly, there was little correlation between phage
Cp6
Cp9
Np3-TATcys
CC
Np3-TATcoil
E coil K coil
Np3-Sec
Cp3
Np3-SRP
pelB leader
SRP leader
TAT leader
GFP derivative
Display protein
Np9-TAT
Np3-TAT
Figure 1. Display constructs created. A graphical representation of the
diﬀerent constructs created, showing the diﬀerent leaders and display
proteins used.
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3E6. In particular, Figure 3B shows that Cp9, Np3-TAT
and Np3-TATcys produced ﬂuorescent phage that were
not, or only weakly, recognized by any of the antibodies,
while one of the least ﬂuorescent phage, those produced by
Cp6, were relatively well recognized by SV5 and the
polyclonal anti-GFP antibody, but not at all by 3E6. All
the remaining phage constructs (Np3-Sec, Np3-SRP, Np3-
TATcoil and Np9-TAT) produced phage particles that
were ﬂuorescent and well recognized by all three
antibodies.
These four best vectors (Np3-Sec, Np3-SRP, Np3-
TATcoil and Np9-TAT) were further analyzed by
western blotting (Figure 3C) using the anti-SV5
antibody. As can be seen, the Np3-sec and Np3-SRP
vectors incorporated the most SV5 epitope, however,
most of this corresponded to a p3-SV5 truncation
product with only 15–20% corresponding to the full
length displayed p3-sfGFP protein. When only the
amount of displayed sfGFP is taken into account, all
four vectors had similar display levels.
Display of modiﬁed sfGFP
The sfGFP used in these studies is extremely stable, and
folds rapidly (72), and as such, is probably not represen-
tative of most cytoplasmic proteins. In order to simulate
less stable, less eﬃciently folding proteins, we investigated
the display of two sfGFP derivatives: myc-GFP contains
the linear myc peptide epitope recognized by the
monoclonal antibody 9E10 (87), while clys-GFP (75)
contains a CDR3 derived from a lysozyme binding
VHH domain that is able to recognize lysozyme as a
soluble protein. On the basis of the results obtained
above, the four most promising vectors (Np3-Sec, Np3-
SRP, Np3-TATcoil and Np9-TAT) were further studied
with these modiﬁed GFPs.
Figure 4A shows that for myc-GFP, the only vector
able to produce phage particles more ﬂuorescent than a
phage displayed antibody (Np3-scFv) was Np3-TATcoil.
The same was true for clys-GFP (Figure 5A). All the other
vectors produced phages that were either less ﬂuorescent,
or only slightly more ﬂuorescent than the antibody phage.
All four vectors, displaying either clys-GFP or myc-
GFP, were able to produce phage particles that could be
recognized by anti-SV5, and in most cases, the polyclonal
anti-GFP antibody. However, only the Np3-TATcoil
vector consistently produced phages that were well
recognized by 3E6, the antibody recognizing the
conformational epitope (Figures 4B and 5B).
Interestingly, the SV5 signals did not correlate with
either 3E6 or the polyclonal anti-GFP signals, with Np3-
Sec and Np3-SRP having the highest SV5, but 3E6 values
barely above the negative control scFv. When these
constructs were tested for recognition by the 9E10
antibody that recognizes the linear myc epitope cloned
within GFP, the Np3-SRP and Np3-Sec vectors gave the
strongest signals, with the Np3-TATcoil and Np9-TAT
vectors producing phages that were not recognized
(Figure 4B).
clys-GFP is able to recognize lysozyme as a pure protein
at a relatively low aﬃnity [1.4mM (75)]. When we carried
out ELISA using phage displaying clys-GFP and
lysozyme as the target (Figure 5B), all four vectors gave
similar relatively low signals.
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Figure 2. 3E6 recognizes a conformational epitope on GFP. (A) The ﬂuorescence of GFP, and (B) its recognition by 3E6, and a polyclonal anti-GFP
antibody under diﬀerent conditions, including (i) native, (ii) treated with SDS and (iii) treated with SDS and 100 C heat treatment. Bound GFP was
detected using polyclonal anti-GFP and m3E6 antibodies followed by HRP labeled corresponding secondary antibodies.
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appeared to be the most suitable for the display of
modiﬁed GFP and therefore perhaps other proteins
expressed in the cytoplasm. However, this result was con-
tradicted by those obtained with 9E10 and lysozyme, in
which Np3-TATcoil gave lower signals. In order to deter-
mine which of these vectors was the most eﬀective within a
selection context, two selection experiments were carried
out. The best three display vectors (Np3-Sec, Np3-SRP
and Np3-TATcoil) displaying myc-GFP were mixed in
equal titers and selected on 9E10, the antibody that
recognizes the linear myc epitope, 3E6, the antibody
recognizing the conformational GFP epitope or
lysozyme, as a negative control. A similar selection was
carried out for the clys-GFP displayed on the three
constructs, using lysozyme, 3E6 or myoglobin (used as a
negative control). In both experiments the identity of the
eluted phages was determined by PCR using speciﬁc
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Figure 3. Expression and display of GFP using diﬀerent display vectors. (A) The ﬂuorescence levels of 10
12 phages displaying sfGFP using the
diﬀerent vector systems are compared. An Np3-sec vector carrying an scFv gene recognizing lysozyme is used as a negative control. (B) Assessment
of GFP display with diﬀerent vectors ELISA signals obtained with phage produced by diﬀerent vectors. The SV5 antibody recognizes a linear peptide
tag found at the C terminus of GFP, the polyclonal anti-GFP recognizes both folded and unfolded GFP, and 3E6 recognizes only correctly folded
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results in Table 4, show clearly that the Np3-TATcoil
vectors were preferentially selected when 3E6 was used
to select either of the modiﬁed GFPs, as well as when
lysozyme was used to select the clys-GFP constructs.
Furthermore, whenever a non-speciﬁc selection was
carried out, the Np3-TATcoil vector gave the lowest
number of colonies. In contrast, the Np3-SRP vector
gave the most colonies under non-speciﬁc selection
conditions, where it constituted  50% of the output.
In the case of selection on the linear myc epitope, the
Np3-SRP vector gave the greatest number of clones,
although the number of clones identiﬁed was only
slightly higher than those with the non-speciﬁc target
(lysozyme).
Display of other ﬂuorescent proteins
As described above, superfolder GFP has been evolved to
be particularly stable, and the ability to display sfGFP,
and modiﬁed variants, may therefore not be representative
of other ﬂuorescent or cytoplasmic proteins. In order to
see whether this vector was suitable for other ﬂuorescent
proteins, wild type GFP (88), cycle 3 GFP (89),
monomeric, dimeric and tetrameric Azami green (74)
and DsRed-T1 (76,90) were cloned into the Np3-ATcoil
and Np3-sec vectors and tested for display.
In the case of the two GFP constructs, only the ﬂu-
orescence of phage displaying cycle 3 GFP using the
Np3-TATcoil vector (Figure 6A) could be measured,
while that of wild-type GFP, or cycle 3 GFP using the
Np3-Sec vector, was no diﬀerent to control phage display-
ing antibody. However, the ﬂuorescence of phage display-
ing cycle 3 GFP was extremely low. Display was also
assessed by ELISA, using 3E6, the polyclonal anti-GFP
antibody and SV5. Figure 6B shows that only the Np3-
TATcoil vector was able to give a detectable 3E6 signal,
indicating that this was the only vector able to display cycle
3GFP inacorrectly folded form.Interestingly, as observed
earlier, although the SV5 signals were high for all vectors,
they tended to be lower in those with higher 3E6 signals.
Unfortunately, we did not have a 3E6-like antibody for
the other ﬂuorescent proteins, and for this reason only
SV5 could be used. The wild-type Azami green protein
is a tetramer (74) that can be converted to a dimer by a
single amino acid mutation, and a monomer by a further
two mutations (74). Figure 6C shows that the Np3-
TATcoil vector was most eﬀective at producing ﬂuores-
cent phage for the monomeric and dimeric Azami green
proteins, while the Np3-Sec was slightly better than the
Np3-TATcoil vector for the tetrameric protein. Figure 6D
shows that SV5 recognized Azami green phage produced
using either Np3-Sec or Np3-TATcoil, but that in general,
the Np3-Sec vector gave higher signals than the Np3-
TATcoil vector- similar to the results obtained with
display of wild-type and cycle 3 GFP.
We also attempted to display DsRed T1 using the Np3-
Sec and Np3-TATcoil vectors. As can be seen in Figure 7,
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Figure 4. Phage ﬂuorescence and display of modiﬁes GFP using diﬀerent display vectors: myc-GFP. (A) Fluorescence of 10
12 phage particles
displaying myc-GFP using diﬀerent vectors. (B) Analysis of myc-GFP display levels by ELISA.
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particles signiﬁcantly more ﬂuorescent than the displayed
scFv (Figure 7A), although a display ELISA using anti-
SV5 (Figure 7B) showed that the Np3-sec DsRed display
level was similar to that of the Np3-sec-scFv.
Mock selection
One concern with the use of the Np3-TATcoil vector is the
possibility that there may be exchange of proteins between
phage, as a result of the fact that displayed proteins are
not covalently bound to g3p. In a ﬁnal experiment to
address this concern, and to determine whether the Np3-
TATcoil vector could be used for selection, phage display-
ing either GFP or mAG using the Np3-TATcoil vector
were mixed at three diﬀerent ratios (Table 3). These
phage mixtures were selected on: (i) 3E6, the antibody
recognizing the conformational epitope on correctly
folded GFP; or (ii) streptavidin beads as a negative
control. The results in Table 3 show clear enrichment of
phage displaying the GFP when selected on 3E6, but not
on streptavidin. In the best case scenario (GFP:mAG
1:5000), enrichment after a single round of selection was
over 2500-fold.
DISCUSSION
In this article we have examined a series of diﬀerent
vectors for their ability to display GFP or GFP variants
that contain loop insertions. GFP was chosen for these
experiments as it is a protein that is not ﬂuorescent
unless correctly folded (62), and so is able to serve as a
surrogate to assess the eﬀectiveness of cytoplasmic protein
0.0
20.0
40.0
60.0
80.0
100.0
120.0
140.0
160.0
180.0
Np3-sec Np3-SRP Np3-TATcoil Np9-TAT Np3-sec-scFv
Display vector
0
0.2
0.4
0.6
0.8
1
1.2
1.4
Np3-sec Np3-SRP Np3-TATcoil Np9-TAT Np3-sec-scFv No Phage
Display vector
anti SV5
anti GFP
m3e6
Lysozyme
N.avidin
B
A
Figure 5. Fluorescence of 10
12 phage particles displaying clys-GFP using diﬀerent vectors. (A) Fluorescence from display of clys-GFP of 10
12 phages.
(B) Analysis of clys-GFP display levels by ELISA.
Table 4. Competitive selection outcome
Displayed
protein
Target
antigen
Display system: % of output
phage
Np3–TATcoil Np3-Sec Np3-SRP
Myc-GFP 9e10 sp 8 32 60
lysozyme nsp 13 26 49
3E6 sp 82 6 14
clys-GFP lysozyme sp 80 5 15
myoglobin nsp 7 38 58
3E6 sp 95 4 1
GFP Lysozyme nsp 5 38 58
Equal titers of phagemid particles made with the Np3–TATcoil, Np3-
Sec and Np3-SRP display vectors displaying the diﬀerent proteins
indicated, were mixed and a single round of selection carried out on
the indicated targets. The designations sp and nsp indicate whether the
target is speciﬁc (sp) or non-speciﬁc (nsp) for the displayed protein.
For each selection the identity of 48 diﬀerent clones was determined
by PCR using vector speciﬁc primers. Each selection was carried
out two or three times and the mean provided in the table (this
explains why the total percentage for each selection does not always
equal 100%).
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conditions. Under normal conditions, functional ﬂuores-
cent GFP can be folded in the bacterial cytoplasm, but
not the bacterial periplasm (61). However, GFP that has
folded in the cytoplasm can be translocated to the
periplasm by the fusion of a TAT leader to the N
terminus (39). Four of the vectors we constructed and
tested were based on previously published vectors
described as being suitable for the display of cytoplasmic
proteins, either because the portion of the phage protein to
which the GFP was fused is normally resident in the cyto-
plasm [Cp3 (19) and Cp6 (20,21)], or because the displayed
protein is translocated from the cytoplasm to the periplasm
by the TAT leader (43) (Np3-TATcys and Np3-TATcoil).
In addition to these, we created additional vectors
(see Figure 1), based on the use of the N and C termini
of p9 (Np9-TAT and Cp9), and direct fusions between the
three diﬀerent leaders (Sec, SRP and TAT) to the N
terminus of p3 (Np3-Sec, Np3-SRP and Np3-TAT).
In addition to using ﬂuorescence as a measure of
protein folding, we also identiﬁed a commercially avail-
able monoclonal antibody (3E6—Q-biogene) that
recognized a conformational epitope destroyed by SDS
and boiling (Figure 2). This allowed us to determine
whether ﬂuorescent GFP observed in phage preparations
was actually displayed, i.e. accessible to external aﬃnity
reagents such as antibodies, or buried within the phage
and consequently not available for binding.
In experiments with sfGFP, vectors that produced ﬂu-
orescent phage (Cp9, Np3-Sec, Np3-TAT, Np3-TATcoil,
Np3-TATcys and Np9-TAT) came from ﬂuorescent
bacteria, and vectors that produced phage that were no
more ﬂuorescent than control phage (Cp6, Cp3 and Np3-
SRP) came from bacteria that had very low or no ﬂuores-
cence (Figure 3A and data not shown). Np3-Sec was an
exception: it produced the most ﬂuorescent bacteria but
phage of relatively low ﬂuorescence. Interestingly, phage
and bacteria produced by the two constructs (Cp3 and
Cp6) based on previously described vectors (19–21) for
the display of cytoplasmic proteins and libraries were
essentially non-ﬂuorescent. Two of the constructs (Cp9
and Np3-TATcys) produced very ﬂuorescent phage, but
were unable to bind 3E6, or only weakly so, indicating
that the GFP in these phage was inaccessible, even if
well expressed and correctly folded. The ability of the
Np3-Sec vector to display sfGFP, as determined by the
production of ﬂuorescent phage that were able to bind
3E6, is in itself signiﬁcant, since GFP has not been
previously displayed using standard phage display
vectors. This probably reﬂects the folding robustness of
superfolder GFP compared to the other GFPs used for
previous attempts.
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Figure 6. Phage ﬂuorescence and display of diﬀerent green ﬂuorescent proteins. (A) Fluorescence of 10
12 cycle3 GFP phages. (B) Display ELISA for
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could also bind to 3E6 were further tested using an addi-
tional two GFP derivatives (clys-GFP and myc-GFP) that
contain binding loops embedded within them conferring
speciﬁc binding activity upon the GFP. The myc-GFP
contains a linear epitope, recognized by the mAb 9E10
(87), that is functional in western blots. For this reason
we believe that myc-GFP does not need to be folded to
be recognized by 9E10. This is in contrast to clys-GFP
that contains the CDR3 from a lysozme binding VHH.
An examination of the structure of this VHH (91), and in
particular the CDR3, in complex with lysozyme, would
suggest that the CDR3 has to be in a particular orientation
to be functional. Furthermore, we have previously shown,
in a ﬂow cytometry assay requiring both ﬂuorescence and
binding activity to reside in a single molecule, that clys-
GFP binds to lysozyme with an aﬃnity of  1.4mM (75),
indicating that correctly folded clys-GFP binds lysozyme.
However, this does not exclude the possibility that poorly
folded clys-GFP is also able to do so.
The insertion of these loops also aﬀects folding, as man-
ifested by reduced bacterial ﬂuorescence and the need for
longer time for ﬂuorescence to develop. For both of these
sfGFP derivatives, the Np3-TATcoil vector produced the
most ﬂuorescent phage, and was the only one that
produced phage recognized by 3E6, indicating that it
was the best at displaying correctly folded versions of
these GFP derivatives. Similarly, in the competitive
selection experiment (Table 4), in which all three vectors
displaying the three diﬀerent GFPs (GFP, clys-GFP and
myc-GFP) competed with one another for binding to
diﬀerent selectors, the Np3-TATcoil vector was always
speciﬁcally selected when 3E6 was used as the selector,
or when lysozyme was used to select the clys-GFP
constructs. This is in contrast to ELISA experiments
using lysozyme and clys-GFP, where the Np3-Sec
construct gave higher signals than the Np3-TATcoil.
This may be due to the diﬀerence between the two
assays: ELISA is carried out using polystyrene plates,
which may denature the lysozyme, while the selection
was carried out in solution which should preserve struc-
tural integrity. In the case of myc-GFP, tested with 9E10,
the Np3-SRP construct gave both the highest ELISA
signal, and was preferentially selected in the mock selec-
tion, reﬂecting the fact that this antibody recognizes a
linear epitope that does not necessarily require folding
(87). However, this result has to be tempered by the obser-
vation that phage produced using Np3-SRP were also the
most commonly selected in all the remaining experiments,
whether the selector was speciﬁc or not, suggesting that
the poorly folded GFP derivatives displayed by this vector
may have been relatively sticky, compared to the others.
On the basis of these results, we believe that the TAT
based display vector, in which the g3p and the displayed
protein are joined together by extremely high aﬃnity
[60pM coils (84)], is the most eﬃcient for the display of
ﬂuorescent proteins in particular, and perhaps
cytoplasmic proteins in general. These results are con-
ﬁrmed in the experiments describing the display of the
other ﬂuorescent proteins (Figure 6). The TAT vector
was able to produce ﬂuorescent phage for all the ﬂuores-
cent proteins except wild-type GFP (88), while the Sec
based vector could only produce signiﬁcantly ﬂuorescent
phage with sfGFP and the dimeric and tetrameric Azami
greens (74). For the GFP based constructs, correct display
could also be assessed using the monoclonal antibody 3E6,
that recognizes a conformational epitope in the correctly
folded protein. The TAT vector consistently gave high
3E6 signals for all the GFP based proteins (sfGFP, myc-
GFP, clys-GFP and cycle 3 GFP), while a positive signal
with the Sec vector was only obtained with the highly
stable sfGFP protein. Display of the two tetrameric
proteins (tetrameric Azami green and DsRed T1) was
signicantly less eﬃcient than display of the other ﬂuores-
cent proteins. This could be because the size of these
tetrameric proteins ( 110kDa) approaches the size limit
for the TAT pathway, or because of the slow folding (and
assembly) kinetics of these proteins. Even though DsRed
T1 was engineered for faster folding (76), in our hands it
still took over 24h for bacteria to become ﬂuorescent.
Given that phage are produced on a far shorter time
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Figure 7. Phage ﬂuorescence and display of DsRed. (A) Fluorescence
of 10
12 dsRed phage. (B) Display ELISA of dsRed.
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folded tetramers are not displayed when the TAT leader
is used: phage production would be expected to be over by
the time the proteins have folded and are competent for
export. This is in contrast to the Np3-Sec vector in which
unfolded protein can be exported and folding may occur
on the phage after assembly.
One surprise of the work presented here, was the
apparent lack of functionality of vectors that have been
previously described as being suitable for the display of
speciﬁc cytoplasmic proteins (19), or cDNA libraries
(20,21). Although we attempted to replicate previously
described vectors as closely as possible by using identical
linker sequences, some elements, such as the peptide tag
[SV5 (79)], and the leader sequence used, were diﬀerent,
and it is conceivable that such (or other) subtle diﬀerences,
are responsible for the inability to display sfGFP and
variants. It is also possible that the speciﬁc proteins
displayed with these other vectors, were more suitable
for these other vectors than the sfGFP we attempted to
display. This may relate to particular folding properties,
or the presence of longer natural peptide linkers that
facilitated display with the Sec leader.
Although there is some overlap, in general, the Sec
leader is suitable for secreted proteins, such as antibodies,
the SRP leader for proteins or domains that fold rapidly,
such as ankyrins and the TAT leader for proteins, which
fold in the cytoplasm, such as ﬂuorescent proteins.
However, unlike the other two leaders, the TAT leader
does not seem to be functional in phage display as a
direct fusion, and has to be used in an alternative
format, such as that described here. This mirrors results
previously obtained with an intracellular carboxylesterase
(85), in which direct fusion was also ineﬀective. The avail-
ability of display vectors using three diﬀerent leaders,
suggests that they should be used together to fully
display complex proteomes. We would expect the combi-
nation of these three vectors to provide greater represen-
tation than any single vector alone. Such a combination of
vectors should be readily applicable to cDNA selection
approaches, in which cDNA, or open reading frame
libraries are displayed on phage and selected with sera
derived from patients with auto-immunity (21,92), viral/
bacterial infections (55,93–98) or neoplasia (47,99–101)
allowing the identiﬁcation of proteins bearing antigenic
epitopes, that may have utility in vaccination, treatment
or diagnosis.
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